It is very important for birth control pills to be effective for women. When they aren’t, the prescription medication can be dangerous for its users. In 2010, a lot of controversy arose when news broke that Bayer Healthcare Pharmaceuticals produced birth control pills that carried dangerous side effects, such as potential blood clots. Today, another type of birth control pill is being recalled for a different reason. Sandoz is recalling one lot of its oral contraception, Estarylla, due to the presence of a placebo tablet in a row of active tablets, according to a press release issued through the U.S. Food & Drug Administration.
The lot of Estarylla, which was distributed to the United States, was packaged in cartons and contained three blister cards of 28 pills. According to the Associated Press, 21 of the pills are active and seven of the 28 pills are placebos. One customer reported finding a placebo pill in an unintended row. The active tables prevent pregnancy and contain a combination of the hormones estrogen and progestin.
To date, the company reports that it has not received any reports of any problems from the recalled medication. Sandoz conducted an internal medical assessment and determined that “the probability of adverse health events is minimal, as the packaging flaw is easily visible and the risk of pregnancy occurring after non-administration of one blue tablet is low,” according to the press release. The recalled medication contains a lot number of LF01213A, an expiration date of 2/2014 and NDC of 00781-4058-15. A third party company manufactured Estarylla for Sandoz, which is the second largest generic pharmaceuticals company worldwide.
Consumers are urged to contact their healthcare provider or Sandoz to report any reactions or problems with Estarylla. Sandoz can be reached at 800-525-2492 24 hours a day, seven days a week.